BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3682016)

  • 1. Critical concentration of cadmium for renal toxicity in rats.
    Tohyama C; Sugihira N; Saito H
    J Toxicol Environ Health; 1987; 22(3):255-9. PubMed ID: 3682016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal toxicity of cadmium-metallothionein and enzymuria in rats.
    Suzuki CA; Cherian MG
    J Pharmacol Exp Ther; 1987 Jan; 240(1):314-9. PubMed ID: 2879904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cadmium, copper, and zinc excretion and their binding to metallothionein in urine of cadmium exposed rats.
    Suzuki Y; Yoshikawa H
    J Toxicol Environ Health; 1981 Sep; 8(3):479-87. PubMed ID: 7345169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of increase in urinary metallothionein of rats repeatedly exposed to cadmium.
    Sugihira N; Tohyama C; Murakami M; Saito H
    Toxicology; 1986 Oct; 41(1):1-9. PubMed ID: 3750333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the structure and function of the kidney of rats chronically exposed to cadmium. I. Biochemical and histopathological studies.
    Brzóska MM; Kamiński M; Supernak-Bobko D; Zwierz K; Moniuszko-Jakoniuk J
    Arch Toxicol; 2003 Jun; 77(6):344-52. PubMed ID: 12799774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of benchmark dose as the threshold levels of urinary cadmium, based on excretion of total protein, beta2-microglobulin, and N-acetyl-beta-D-glucosaminidase in cadmium nonpolluted regions in Japan.
    Kobayashi E; Suwazono Y; Uetani M; Inaba T; Oishi M; Kido T; Nishijo M; Nakagawa H; Nogawa K
    Environ Res; 2006 Jul; 101(3):401-6. PubMed ID: 16436274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal damage induced by cadmium-metallothionein: effects on biochemical indicators.
    Sugihira N; Sagai M; Suzuki KT
    Toxicology; 1987 Apr; 44(1):1-11. PubMed ID: 2882622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of biomarkers of exposure to inorganic mercury, lead, or cadmium in controlling occupational and environmental risks of nephrotoxicity.
    Roels HA; Hoet P; Lison D
    Ren Fail; 1999; 21(3-4):251-62. PubMed ID: 10416202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Urinary N-acetyl-beta-D-glucosaminidase and its isoenzymes in smoking and non-smoking workers at copper foundry occupational co-exposed to arsenic cadmium and lead].
    Milnerowicz H; Bizoń A; Witt K; Antonowicz-Juchniewicz J; Andrzejak R
    Przegl Lek; 2008; 65(10):518-21. PubMed ID: 19189537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal accumulation of cadmium and nephropathy following long-term administration of cadmium-metallothionein.
    Min KS; Onosaka S; Tanaka K
    Toxicol Appl Pharmacol; 1996 Nov; 141(1):102-9. PubMed ID: 8917681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal effects of cadmium exposure in cadmium nonpolluted areas in Japan.
    Suwazono Y; Kobayashi E; Okubo Y; Nogawa K; Kido T; Nakagawa H
    Environ Res; 2000 Sep; 84(1):44-55. PubMed ID: 10991781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of kidney dysfunction in humans - relationship to cadmium dose, metallothionein, immunological and metabolic factors.
    Nordberg GF; Jin T; Wu X; Lu J; Chen L; Lei L; Hong F; Nordberg M
    Biochimie; 2009 Oct; 91(10):1282-5. PubMed ID: 19563860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nephrotoxicity of intravenously administered cadmium-metallothionein: effect of dose, mode of administration, and preexisting renal cadmium burden.
    Vestergaard P; Shaikh ZA
    Toxicol Appl Pharmacol; 1994 Jun; 126(2):240-7. PubMed ID: 8209377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased hepatic and decreased urinary metallothionein in rats after cessation of oral cadmium exposure.
    Liang Y; Li H; Xiang C; Lei L; Jin T; Nordberg M; Nordberg GF
    Basic Clin Pharmacol Toxicol; 2010 Apr; 106(4):348-55. PubMed ID: 20030629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical exposure level of cadmium for elevated urinary metallothionein--an occupational population study in China.
    Chen L; Jin T; Huang B; Nordberg G; Nordberg M
    Toxicol Appl Pharmacol; 2006 Aug; 215(1):93-9. PubMed ID: 16510161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary excretion of copper bound to low molecular weight proteins in the population exposed to cadmium in community and occupational environments.
    Wrońska-Nofer T; Hałatek T; Wiśniewksa-Knypl J; Raźniewska G
    Int J Occup Med Environ Health; 1994; 7(4):345-53. PubMed ID: 7719661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-response relationship for renal dysfunction in a population environmentally exposed to cadmium.
    Nogawa K; Kido T; Shaikh ZA
    IARC Sci Publ; 1992; (118):311-8. PubMed ID: 1303957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of benchmark dose for renal dysfunction in a cadmium non-polluted area in Japan.
    Kobayashi E; Suwazono Y; Uetani M; Inaba T; Oishi M; Kido T; Nishijo M; Nakagawa H; Nogawa K
    J Appl Toxicol; 2006; 26(4):351-5. PubMed ID: 16791912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrotoxicity of repeated injections of cadmium-metallothionein in rats.
    Wang XP; Chan HM; Goyer RA; Cherian MG
    Toxicol Appl Pharmacol; 1993 Mar; 119(1):11-6. PubMed ID: 8470114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shifts in the dose-effect relationship for the nephropathy induced by cadmium-metallothionein in rats after a reduction in renal mass.
    Zalups RK; Gelein RM; Cherian MG
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1256-66. PubMed ID: 1527728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.